0001829126-22-008372.txt : 20220418 0001829126-22-008372.hdr.sgml : 20220418 20220418215523 ACCESSION NUMBER: 0001829126-22-008372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220414 FILED AS OF DATE: 20220418 DATE AS OF CHANGE: 20220418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PURA VIDA INVESTMENTS, LLC CENTRAL INDEX KEY: 0001590144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 22833341 BUSINESS ADDRESS: STREET 1: 512 W 22ND STREET STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10111 BUSINESS PHONE: 646-597-6995 MAIL ADDRESS: STREET 1: 512 W 22ND STREET STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kamen Efrem CENTRAL INDEX KEY: 0001789193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 22833340 MAIL ADDRESS: STREET 1: 512 W 22ND STREET STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncocyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-409-7600 MAIL ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20200213 FORMER COMPANY: FORMER CONFORMED NAME: Oncocyte Corp DATE OF NAME CHANGE: 20200205 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20150513 4 1 ownership.xml 4 X0306 4 2022-04-14 0 0001642380 Oncocyte Corp OCX 0001590144 PURA VIDA INVESTMENTS, LLC 512 W 22ND STREET 7TH FLOOR NEW YORK NY 10011 0 0 1 0 0001789193 Kamen Efrem C/O PURA VIDA INVESTMENTS, LLC 888 7TH AVENUE, 6TH FLOOR NEW YORK NY 10106 0 0 1 0 Common Stock 2022-04-14 4 P 0 1665898 1.3325 A 7350447 I By Pura Vida Master Fund, Ltd. Common Stock 2022-04-14 4 P 0 30790 1.2270 A 7381237 I By Pura Vida Master Fund, Ltd. Common Stock 2022-04-14 4 P 0 92370 1.2600 A 7473607 I By Pura Vida Master Fund, Ltd. Common Stock 2022-04-14 4 P 0 1916419 1.3325 A 8455823 I By the Managed Accounts Common Stock 2022-04-14 4 P 0 19210 1.2270 A 8475033 I By the Managed Accounts Common Stock 2022-04-14 4 P 0 57630 1.2600 A 8532663 I By the Managed Accounts Common Stock 2022-04-14 4 P 0 767952 1.3325 A 767952 I By Pura Vida X Fund LP Common Stock 2022-04-14 4 P 0 1381438 1.3325 A 1381438 I By the Retirement Trust Warrant to purchase common stock 1.53 2022-04-14 4 P 0 832949 A 2022-04-19 2027-04-19 Common Stock 832949 832949 I By Pura Vida Master Fund, Ltd. Warrant to purchase common stock 1.53 2022-04-14 4 P 0 383976 A 2022-04-19 2027-04-19 Common Stock 383976 383976 I By Pura Vida X Fund LP Warrant to purchase common stock 1.53 2022-04-14 4 P 0 690719 A 2022-04-19 2027-04-19 Common Stock 690719 690719 I By the Retirement Trust Warrant to purchase common stock 1.53 2022-04-14 4 P 0 958209 A 2022-04-19 2027-04-19 Common Stock 958209 958209 I By the Managed Accounts Each share of common stock was purchased together with one warrant to purchase 0.5 shares of common stock at a combined offering price of $1.3325. Shares reported herein are owned by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund"), Pura Vida X Fund LP (the "Pura Vida X Fund"), Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust"), and certain separately managed accounts (the "Managed Accounts," collectively the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI. By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any. The Warrants are subject to an ownership blocker provision that prevents the holder from exercising the Warrants if it would beneficially hold more than 19.99% of the common stock following such exercise. /s/ Efrem Kamen, Managing Member of Pura Vida Investments, LLC 2022-04-18 /s/ Efrem Kamen 2022-04-18